These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 15937546)
1. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546 [TBL] [Abstract][Full Text] [Related]
2. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Weeks BH; He W; Olson KL; Wang XJ Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377 [TBL] [Abstract][Full Text] [Related]
3. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Go C; Li P; Wang XJ Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma. Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790 [TBL] [Abstract][Full Text] [Related]
5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J; Dai C; Liu Y J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870 [TBL] [Abstract][Full Text] [Related]
6. Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transition. Lenferink AE; Magoon J; Cantin C; O'Connor-McCourt MD Breast Cancer Res; 2004; 6(5):R514-30. PubMed ID: 15318933 [TBL] [Abstract][Full Text] [Related]
7. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1. Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608 [TBL] [Abstract][Full Text] [Related]
8. Autophagy links β-catenin and Smad signaling to promote epithelial-mesenchymal transition via upregulation of integrin linked kinase. Pang M; Wang H; Rao P; Zhao Y; Xie J; Cao Q; Wang Y; Wang YM; Lee VW; Alexander SI; Harris DC; Zheng G Int J Biochem Cell Biol; 2016 Jul; 76():123-34. PubMed ID: 27177845 [TBL] [Abstract][Full Text] [Related]
9. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization. Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292 [TBL] [Abstract][Full Text] [Related]
11. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. Davies M; Robinson M; Smith E; Huntley S; Prime S; Paterson I J Cell Biochem; 2005 Aug; 95(5):918-31. PubMed ID: 15861394 [TBL] [Abstract][Full Text] [Related]
12. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799 [TBL] [Abstract][Full Text] [Related]
13. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes. Räsänen K; Vaheri A J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617 [TBL] [Abstract][Full Text] [Related]
14. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase. Wang D; Shen Q; Chen YQ; Wang MH Oncogene; 2004 Mar; 23(9):1668-80. PubMed ID: 15001985 [TBL] [Abstract][Full Text] [Related]
15. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Amendt C; Schirmacher P; Weber H; Blessing M Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311 [TBL] [Abstract][Full Text] [Related]
16. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis. Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465 [TBL] [Abstract][Full Text] [Related]
18. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. Li Y; Yang J; Dai C; Wu C; Liu Y J Clin Invest; 2003 Aug; 112(4):503-16. PubMed ID: 12925691 [TBL] [Abstract][Full Text] [Related]
19. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062 [TBL] [Abstract][Full Text] [Related]
20. Hydrogen Sulfide Inhibits Transforming Growth Factor-β1-Induced EMT via Wnt/Catenin Pathway. Guo L; Peng W; Tao J; Lan Z; Hei H; Tian L; Pan W; Wang L; Zhang X PLoS One; 2016; 11(1):e0147018. PubMed ID: 26760502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]